Epidemiological and clinical complexity of amoxicillin-clavulanate- resistant Escherichia coli

Journal of Clinical Microbiology

Volumn 51, Issue 7, 2013, Pages 2414-2417

  Rodríguez Baño, Jesús ^a,b,c   Oteo, Jesús ^c,d   Ortega, Adriana ^d   Villar, Macarena ^a   Conejo, M Carmen ^b,c   Bou, Germán ^c,e   Aranzamendi Zaldumbide, Maitane ^f   Cercenado, Emilia ^g   Gurguí, Mercè ^c,h   Martínez Martínez, Luis ^c,f,i   Merino, María ^c,e   Rivera, Alba ^h   Oliver, Antonio ^c,j   Weber, Irene ^j   Pascual, Alvaro ^a,b,c   Bartolomé, Rosa M ^k   Gónzalez López, Juan José ^k   Campos, José ^c,d,l  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^b UNIVERSITY OF SEVILLE   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e HOSPITAL JUAN CANALEJO   (Spain)

^f HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^g HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^h HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

ⁱ UNIVERSITY OF CANTABRIA   (Spain)

^j HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^k HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^l CSIC   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN PLUS CLAVULANIC ACID; CARBAPENEM; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; COTRIMOXAZOLE; PIPERACILLIN PLUS TAZOBACTAM; ANTIINFECTIVE AGENT;

ABDOMINAL INFECTION; ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; DISEASE PREDISPOSITION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTICENTER STUDY; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SCHOOL CHILD; URINARY TRACT INFECTION; CROSS-SECTIONAL STUDY; DRUG EFFECTS; ESCHERICHIA COLI INFECTIONS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY (TOPIC); PATHOLOGY; URINARY TRACT INFECTIONS; YOUNG ADULT;

ESCHERICHIA COLI;

ADOLESCENT; ADULT; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; BACTEREMIA; BETA-LACTAM RESISTANCE; CHILD; CROSS-SECTIONAL STUDIES; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; URINARY TRACT INFECTIONS; YOUNG ADULT;

EID: 84879455309     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00999-13     Document Type: Article

References (14)

1. Goossens H, Ferech M, Vander Stichele R, Elseviers M, ESAC Project Group. 2005. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365:579-587.
2. Campos J, Ferech M, Lázaro E, de Abajo F, Oteo J, Stephens P, Goossens H. 2007. Surveillance of outpatient antibiotic consumption in Spain according to sales data and reimbursement data. J. Antimicrob. Chemother. 60:698-701.
3. Oteo J, Campos J, Lázaro E, Cuevas O, García-Cobos S, Pérez-Vázquez M, de Abajo FJ, Spanish Members of EARSS. 2008. Increased amoxicillin-clavulanic acid resistance in Escherichia coli blood isolates, Spain. Emerg. Infect. Dis. 14:1259-1262.
4. Blaettler L, Mertz D, Frei R, Elzi L, Widmer AF, Battegay M, Flückiger U. 2009. Secular trends and risk factors for antimicrobial resistance in Escherichia coli in Switzerland 1997-2007. Infection 37:534-539.
5. Maraki S, Mantadakis E, Michailidis L, Samonis G. 11 July 2012. Changing antibiotic susceptibilities of community-acquired uropathogens in Greece, 2005-2010. J. Microbiol. Immunol. Infect. [Epub ahead of print.] doi:10.1016/j.jmii.2012.05.012.
6. Ortega A, Oteo J, Aranzamendi-Zaldumbide M, Bartolomé RM, Bou G, Cercenado E, Conejo MC, González-López JJ, Marín M, Martínez-Martínez L, Merino M, Navarro F, Oliver A, Pascual A, Rivera A, Rodríguez-Baño J, Weber I, Aracil B, Campos J. 2012. Spanish multicenter study of the epidemiology and mechanisms of amoxicillinclavulanate resistance in Escherichia coli. Antimicrob. Agents Chemother. 56:3576-3581.
7. Rodríguez-Baño J, Alcalá JC, Cisneros JM, Grill F, Oliver A, Horcajada JP, Tórtola T, Mirelis B, Navarro G, Cuenca M, Esteve M, Peña C, Llanos AC, Cantón R, Pascual A. 2008. Community infections caused by extended-spectrum β-lactamase-producing Escherichia coli. Arch. Intern. Med. 168:1897-1902.
8. Horan TC, Andrus M, Dudeck MA. 2008. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am. J. Infect. Control 36:309-332.
9. Clinical and Laboratory Standards Institute. 2012. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 9th ed. Approved standard M07-A9. Clinical and Laboratory Standards Institute, Wayne, PA.
10. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL. 2012. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 18: 268-281.
11. Rodríguez-Baño J, Miró E, Villar M, Coelho A, Gozalo M, Borrell N, Bou G, Conejo MC, Pomar V, Aracil B, Larrosa N, Agüero J, Oliver A, Fernández A, Oteo J, Pascual A, Navarro F. 2012. Colonisation and infection due to Enterobacteriaceae producing plasmid-mediated AmpC β-lactamases. J. Infect. 64:176-183.
12. Paterson DL. 2004. "Collateral damage" from cephalosporin or quinolone antibiotic therapy. Clin. Infect. Dis. 38(Suppl 4):S341-S345. doi:10.1086/382690.
13. Rodríguez-Baño J, Mingorance J, Fernández-Romero N, Serrano L, López-Cerero L, Pascual A, ESBL-REIPI Group. 2012. Virulence profiles of bacteremic extended-spectrum β-lactamase-producing Escherichia coli: association with epidemiological and clinical features. PLoS One 7:e44238. doi:10.1371/journal.pone.0044238.
14. Picard B, Garcia JS, Gouriou S, Duriez P, Brahimi N, Bingen E, Elion J, Denamur E. 1999. The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect. Immun. 67:546-553. III